Callan Family Office’s Nomura Holdings NMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.52M Buy
173,593
+7,017
+4% +$58.4K 0.03% 476
2026
Q1
$1.31M Sell
166,576
-698
-0.4% -$6.01K 0.03% 485
2025
Q4
$1.4M Buy
167,274
+85,278
+104% +$637K 0.03% 449
2025
Q3
$596K Sell
81,996
-47,899
-37% -$336K 0.02% 490
2025
Q2
$855K Buy
129,895
+78,438
+152% +$459K 0.03% 435
2025
Q1
$316K Sell
51,457
-8,726
-14% -$55.5K 0.02% 412
2024
Q4
$348K Buy
+60,183
New +$342K 0.02% 449

Other funds holding NMR

Callan Family Office's NMR Position: Q2 2026 in Review

Callan Family Office increased its Nomura Holdings (NMR) stake by 4.2% in Q2 2026, buying an estimated $58.4K and bringing the position to 173,593 shares worth $1.52M. The position accounts for 0.03% of the portfolio, ranked #476.

Callan Family Office first reported a position in NMR in Q4 2024 and has held it in 7 quarters since. 300 funds tracked by Wall St. Rank hold NMR as of Q2 2026.

  • Callan Family Office held 173,593 shares of Nomura Holdings worth $1.52M as of Q2 2026.
  • Callan Family Office bought 7,017 Nomura Holdings shares in Q2 2026, an estimated $58.4K.
  • Nomura Holdings made up 0.03% of Callan Family Office's portfolio in Q2 2026, its #476 holding.
  • Callan Family Office first reported a position in Nomura Holdings in Q4 2024 and has held it in 7 quarters since.
  • 300 funds tracked by Wall St. Rank held Nomura Holdings as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.